» Articles » PMID: 35228476

Use of Immunosuppressive Therapy in the Treatment of IgA-dominant Infection-related Glomerulonephritis

Abstract

A 51-year-old Japanese man who experienced colon cancer recurrence following primary and metastatic lesion resection was hospitalized due to facial cellulitis with febrile neutropenia and purpura on his lower extremities after chemotherapy. It was complicated by rapidly progressive glomerulonephritis. He was diagnosed with immunoglobulin A (IgA)-dominant endocapillary proliferative glomerulonephritis based on kidney histology. His glomeruli were positive for the nephritis-associated plasmin receptor, plasmin activity and galactose-deficient IgA1 (Gd-IgA1). A skin biopsy immunofluorescence study revealed IgA deposition within perivascular regions but no Gd-IgA1 deposition. The final diagnosis was IgA-dominant infection-related glomerulonephritis (IRGN). The patient's renal function returned to normal after receiving immunosuppressive therapy that consisted of a glucocorticoid and a cyclophosphamide. Immunosuppressive therapy should be considered in cases of IRGN if the patient's infection is completely under control.

Citing Articles

Proliferative glomerulonephritis with monoclonal immunoglobulin G3 lambda deposits accompanied by glomerular positive staining for nephritis-associated plasmin receptor and related plasmin activity: A report of two cases.

Uchida T, Oda T, Hoshino T, Sakai T, Kojima A, Inoue D Front Med (Lausanne). 2023; 9:1059575.

PMID: 36714098 PMC: 9877447. DOI: 10.3389/fmed.2022.1059575.


Glomerulonephritis: immunopathogenesis and immunotherapy.

Anders H, Kitching A, Leung N, Romagnani P Nat Rev Immunol. 2023; 23(7):453-471.

PMID: 36635359 PMC: 9838307. DOI: 10.1038/s41577-022-00816-y.

References
1.
Satoskar A, Parikh S, Nadasdy T . Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2019; 16(1):32-50. DOI: 10.1038/s41581-019-0178-8. View

2.
Nasr S, Radhakrishnan J, DAgati V . Bacterial infection-related glomerulonephritis in adults. Kidney Int. 2013; 83(5):792-803. DOI: 10.1038/ki.2012.407. View

3.
Nasr S, DAgati V . IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract. 2011; 119(1):c18-25. DOI: 10.1159/000324180. View

4.
Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T . IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018; 93(3):700-705. DOI: 10.1016/j.kint.2017.10.019. View

5.
Radhakrishnan J, Cattran D . The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. Kidney Int. 2012; 82(8):840-56. DOI: 10.1038/ki.2012.280. View